FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4673912015 | Allylestrenol micronized (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4673913013 | Allylestrenol micronized | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4673914019 | Allylestrenol micronised | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Allylestrenol micronized (substance) | Is a | Steroid hormone | true | Inferred relationship | Some | ||
| Allylestrenol micronized (substance) | Is a | Estrane | true | Inferred relationship | Some | ||
| Allylestrenol micronized (substance) | Is a | Synthetic progestogen (substance) | true | Inferred relationship | Some | ||
| Allylestrenol micronized (substance) | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | Progesterone receptor agonist (disposition) | true | Inferred relationship | Some | ||
| Allylestrenol micronized (substance) | This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. | Allylestrenol (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Allylestrenol micronized 5 mg oral tablet | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | True | Allylestrenol micronized (substance) | Inferred relationship | Some | 1 |
| Allylestrenol micronized 5 mg oral tablet | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | True | Allylestrenol micronized (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets